MXPA03000182A - Efectividad terapeutica de mejoria de inhalacion de oxido nitrico. - Google Patents

Efectividad terapeutica de mejoria de inhalacion de oxido nitrico.

Info

Publication number
MXPA03000182A
MXPA03000182A MXPA03000182A MXPA03000182A MXPA03000182A MX PA03000182 A MXPA03000182 A MX PA03000182A MX PA03000182 A MXPA03000182 A MX PA03000182A MX PA03000182 A MXPA03000182 A MX PA03000182A MX PA03000182 A MXPA03000182 A MX PA03000182A
Authority
MX
Mexico
Prior art keywords
inhalation
effective amount
nitric oxide
administering
therapeutically effective
Prior art date
Application number
MXPA03000182A
Other languages
English (en)
Spanish (es)
Inventor
Kenneth Bloch
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of MXPA03000182A publication Critical patent/MXPA03000182A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MXPA03000182A 2000-06-28 2001-06-22 Efectividad terapeutica de mejoria de inhalacion de oxido nitrico. MXPA03000182A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/605,900 US6601580B1 (en) 2000-06-28 2000-06-28 Enhancing therapeutic effectiveness of nitric oxide inhalation
PCT/US2001/041102 WO2002000175A2 (en) 2000-06-28 2001-06-22 Enhancing therapeutic effectiveness of nitric oxide inhalation

Publications (1)

Publication Number Publication Date
MXPA03000182A true MXPA03000182A (es) 2004-02-26

Family

ID=24425654

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000182A MXPA03000182A (es) 2000-06-28 2001-06-22 Efectividad terapeutica de mejoria de inhalacion de oxido nitrico.

Country Status (10)

Country Link
US (2) US6601580B1 (enExample)
EP (1) EP1301076A4 (enExample)
JP (1) JP2004509850A (enExample)
KR (1) KR100849103B1 (enExample)
CN (1) CN100488497C (enExample)
AU (2) AU2001273622B2 (enExample)
CA (1) CA2414409A1 (enExample)
IL (1) IL153702A0 (enExample)
MX (1) MXPA03000182A (enExample)
WO (1) WO2002000175A2 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656452B1 (en) 1997-10-21 2003-12-02 The General Hospital Corporation Use of inhaled NO as anti-inflammatory agent
CA2254645A1 (en) * 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US20070086954A1 (en) * 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US7516742B2 (en) * 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
US7335181B2 (en) * 2000-12-26 2008-02-26 Pulmonox Technologies Corporation Nitric oxide decontamination of the upper respiratory tract
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
GB0125357D0 (en) * 2001-10-22 2001-12-12 Univ Brighton Improvements relating to catalytic antioxidants
CN1596111A (zh) * 2001-11-29 2005-03-16 桑得医药品公司 减轻化疗引起的不良效果的组合物及方法
PT1471902E (pt) * 2002-01-04 2014-09-09 Sound Pharmaceuticals Inc Métodos para o tratamento da perda de audição
EA200500062A1 (ru) * 2002-06-21 2005-06-30 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Фармацевтическое применение оксида азота, гемоксигеназы-1 и продуктов деградации гема
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US9138707B2 (en) 2002-12-10 2015-09-22 Sy Kimball Portable, nitric oxide generator
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
AU2004257693B8 (en) 2003-07-09 2009-08-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US20050255178A1 (en) * 2004-02-04 2005-11-17 Bloch Kenneth D Enhancing the effectiveness of an inhaled therapeutic gas
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
MXPA06013111A (es) * 2004-05-11 2007-05-23 Sensormedics Corp Dosificacion intermitente de gas de oxido nitrico.
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
AU2006220626A1 (en) * 2005-03-08 2006-09-14 Sound Pharmaceuticals Incorporated Methods and compositions for treating cancer
US8557300B2 (en) * 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
WO2007057763A2 (en) * 2005-11-18 2007-05-24 Pulmonox Technologies Corporation Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
US8790715B2 (en) 2006-02-16 2014-07-29 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
WO2007136789A2 (en) * 2006-05-19 2007-11-29 Medimmune, Inc. Methods of preventing, treating or ameliorating enhanced respiratory disease via innate immune mechanisms
FR2902002B1 (fr) * 2006-06-12 2010-08-27 Lvmh Rech Composition cosmetique anti-radicaux libres
US8079998B2 (en) * 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
TWI474824B (zh) * 2006-11-07 2015-03-01 Gen Hospital Corp 血管活性氧載劑所引發之血管收縮之減輕
US20080193566A1 (en) * 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
WO2009063226A2 (en) * 2007-11-12 2009-05-22 Karolinska Institutet Innovations Ab Methods relating to breathing disorders
AU2008345034A1 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
US9649467B2 (en) 2008-01-31 2017-05-16 Syk Technologies, Llc Nitric oxide reactor and distributor apparatus and method
US8434475B2 (en) 2008-01-31 2013-05-07 Genosys, Inc. Nitric oxide reactor and distributor apparatus and method
US8720436B2 (en) * 2008-01-31 2014-05-13 Genosys, Inc. Nitric oxide gel apparatus and method
US8501090B2 (en) * 2008-03-24 2013-08-06 Christian S. Minton Anti-microbial gas apparatus and method
JP2011010865A (ja) 2009-06-30 2011-01-20 Ikaria Holdings Inc 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法
JP5581500B2 (ja) * 2010-03-10 2014-09-03 学校法人北里研究所 虚血再灌流障害軽減用治療剤および治療装置
US8685467B2 (en) 2010-08-03 2014-04-01 J. W. Randolph Miller Nitric oxide generation, dilution, and topical application apparatus and method
WO2012131412A2 (en) 2011-03-31 2012-10-04 Szabo Laszlo Gabor Pharmaceutical composition containing no, process for the preparation and use thereof
JP6389125B2 (ja) 2011-11-07 2018-09-12 ザ ジェネラル ホスピタル コーポレイション 赤血球の処理法
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
EP2908137A1 (en) * 2014-02-14 2015-08-19 Institut Pasteur Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
JP2014141536A (ja) * 2014-05-16 2014-08-07 Kitasato Institute 虚血再灌流障害軽減用治療剤および治療装置
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
US20170182088A1 (en) * 2015-12-28 2017-06-29 Geno Llc Method and apparatus for administering nitric oxide with supplemental drugs
WO2017132275A1 (en) 2016-01-27 2017-08-03 Syk Technologies, Llc Nitric oxide topical application apparatus and methods
US11602555B2 (en) 2016-11-17 2023-03-14 Renovion, Inc. Treatment of respiratory tract diseases and infections with ascorbic acid compositions
ES3008699T3 (en) 2017-11-17 2025-03-24 Renovion Inc Stable ascorbic acid compositions and methods of using the same
CN109169638A (zh) * 2018-11-12 2019-01-11 苏州瑞徕生物科技有限公司 一种细胞保存液及其用途
US12459820B2 (en) 2020-06-11 2025-11-04 J. W. Randolph Miller Stabilized and NO2-inhibited nitric oxide generating gels for inhaled nitric oxide therapy
KR20240131358A (ko) 2022-01-04 2024-08-30 레노비온, 아이엔씨. 글루타치온 염을 포함하는 수용액

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5570683A (en) 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
DE69133584D1 (de) 1990-12-05 2007-12-13 Gen Hospital Corp Vorrichtung zum Behandeln einen Lungengefässverengung und von Asthma
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
AU6528494A (en) * 1993-04-06 1994-10-24 Brigham And Women's Hospital Nitric oxide combination therapy
US5427797A (en) 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
US5728705A (en) 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
WO1996039409A1 (en) * 1995-06-05 1996-12-12 Nitromed, Inc. Nitrosylated and nitrated superoxide oxidants and reductants
DK0914103T3 (da) 1996-04-05 2006-10-23 Gen Hospital Corp Behandling af hæmoglobinopati
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
SE9903985D0 (sv) * 1999-11-03 1999-11-03 Aga Ab Use of nitric oxide
CN100486573C (zh) * 1999-12-23 2009-05-13 硝化医药股份有限公司 硝基化的和亚硝基化的环加氧酶-2抑制剂、组合物及其用途

Also Published As

Publication number Publication date
EP1301076A2 (en) 2003-04-16
US20030202969A1 (en) 2003-10-30
AU7362201A (en) 2002-01-08
CA2414409A1 (en) 2002-01-03
US6601580B1 (en) 2003-08-05
IL153702A0 (en) 2003-07-06
AU2001273622B2 (en) 2007-05-10
JP2004509850A (ja) 2004-04-02
US6935334B2 (en) 2005-08-30
CN1635923A (zh) 2005-07-06
KR100849103B1 (ko) 2008-07-30
WO2002000175A2 (en) 2002-01-03
WO2002000175A3 (en) 2002-08-15
KR20030029530A (ko) 2003-04-14
CN100488497C (zh) 2009-05-20
EP1301076A4 (en) 2004-09-22

Similar Documents

Publication Publication Date Title
MXPA03000182A (es) Efectividad terapeutica de mejoria de inhalacion de oxido nitrico.
WO2001054679A3 (en) Transdermal composition containing an anesthetic and a vasodilator agent
JP2004509850A5 (enExample)
WO2001068040A3 (en) The use of plant extracts and sugars to protect keratinous tissue
WO2004014314A3 (en) Methods and compositions concerning poxviruses and cancer
TW200730537A (en) Methods and compositions for treating hepatitis C virus
WO2005107793A3 (en) Ngal for reduction and amelioration of ischemic and nephrotoxic injuries
WO2001093909A3 (en) Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor
WO2007134241A3 (en) Nasal delivery of therapeutic agents using tight junction agonists
IL192100A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
WO2004052308A3 (en) Topical anti-infective formulations
WO2004046309A3 (en) Methods for inhibiting viral replication in vivo
WO2007064658A3 (en) Safe and effective methods of administering therapeutic agents
WO2000066107A3 (en) Antimalarian agents for the treatment of asthma
WO2008067549A3 (en) Stabilized zolpidem pharmaceutical compositions
WO2007075695A3 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
WO2003097050A3 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
WO2000072835A3 (en) Topical application of muscarinic and opioid agents for treatment of tinnitus
WO2004110392A3 (en) Compositions and methods for treating coronavirus infection and sars
WO2003051290A3 (en) Treating b-cell mediated diseases by modulating dr6 activity
PT1220676E (pt) Prevencao do cancro colorrectal
BR0316054A (pt) Compostos para tratamento de dependência e privação de tabaco
MXPA05003616A (es) Composiciones que comprenden anfotericina b altamente purificada.
WO2007133749A3 (en) Methods and compositions for treating and preventing peripheral nerve damage
WO2007150049A3 (en) Lactoferrin as a radioprotective agent

Legal Events

Date Code Title Description
FA Abandonment or withdrawal